Sign in
1093 POPULATION PHARMACOKINETIC (PK) ANALYSIS OF RIBAVIRIN (COPEGUS) IN CHRONIC HEPATITIS C (CHC) PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) LEADS TO CHANGES IN RECOMMENDED DOSING
Journal article   Peer reviewed

1093 POPULATION PHARMACOKINETIC (PK) ANALYSIS OF RIBAVIRIN (COPEGUS) IN CHRONIC HEPATITIS C (CHC) PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) LEADS TO CHANGES IN RECOMMENDED DOSING

B. Brennan, M.O. Magnusson, J.J. Wilkins, P. Martin, K. Nieforth, J. Solsky and C. Wat
Journal of hepatology, Vol.56, pp.S430-S430
2012-04

Metrics

6 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

undefined

Source: InCites

Details